Sort by
Search results
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
Antithrombin & Heparin Cofactor II Deficient Plasma
For any in vitro protocol or research study where a source of human AT/HCII deficient plasma is required.
Heparin Cofactor II Deficient Plasma
For any in vitro protocol or research study where a source of human heparin cofactor II deficient plasma is required.
BIOPHEN Factor IX (6)
Assay proposed for the measurement of factor IX activity in research applications.
BIOPHEN Factor IX (2.5)
Assay proposed for the measurement of factor IX activity in research applications.
CRYOcheck Low Fibrinogen Control, frozen
Abnormal control for use in quantitative fibrinogen assays.
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.
CRYOcheck Lupus Weak Positive Control, frozen
Weak positive control for lupus anticoagulant assays.
CRYOcheck Lupus Weak Positive Control, frozen
Weak positive control for lupus anticoagulant assays.
CRYOcheck APCR Positive Control, frozen
Positive control for the clot-based assessment of activated protein C resistance in human plasma.